Neuroprotection (Focal Ischemia) and Neurotoxicity (Electroencephalographic) Studies in Rats with AHN649, a 3-Amino Analog of Dextromethorphan and Low-Affinity N-Methyl-d-Aspartate Antagonist
- 1 October 1999
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 291 (1) , 399-408
- https://doi.org/10.1016/s0022-3565(24)35114-6
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- YM90K, an AMPA receptor antagonist, protects against ischemic damage caused by permanent and transient middle cerebral artery occlusion in rats.Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1998
- Modulation of the neuronal response to N-Methyl-D-Aspartate by selective sigma2 ligandsSynapse, 1998
- EEG seizure activity and behavioral neurotoxicity produced by (+)-MK801, but not the glycine site antagonist L-687,414, in the ratNeuropharmacology, 1996
- Role of calcium in sigma-mediated neuroprotection in rat primary cortical neuronsBrain Research, 1995
- σ receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal culturesBrain Research, 1995
- Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepinesTrends in Pharmacological Sciences, 1993
- Immediate or delayed mild hypothermia prevents focal cerebral infarctionBrain Research, 1992
- Background Review and Current Concepts of Reperfusion InjuryArchives of Neurology, 1990
- The effects of N-methyl-D-aspartate receptor blockade with MK-801 upon the relationship between cerebral blood flow and glucose utilisationBrain Research, 1990
- Blood-brain barrier disruption and exacerbation of ischemic brain edema after restoration of blood flow in experimental focal cerebral ischemiaActa Neuropathologica, 1988